Cardiovascular Diseases

Prediabetes Remission Confers Long-Term Protection against CVD

Achieving remission of prediabetes was associated with an approximately 50% lower long-term risk of death from cardiovascular disease (CVD) or hospitalization for heart failure, with benefits persisting for decades in two landmark diabetes prevention cohorts. In post hoc analyses of the US Diabetes Prevention Program Outcomes Study and the Chinese DaQing Diabetes Prevention Outcomes Study, individuals who restored normal glucose regulation after lifestyle intervention had substantially lower event rates over 20 to 30 years of follow-up compared with those who did not achieve remission, even after rigorous adjustment for baseline differences. These findings were consistent across both populations and confirmed in pooled meta-analyses, demonstrating a durable “legacy effect” that outlasted the active intervention period. Together, the results suggest that targeting prediabetes remission—alongside established weight loss—may represent a powerful and novel strategy for long-term CVD prevention. Source: https://www.thelancet.com/

hyangiu

Recent Posts

Early-Life Sugar Restriction Linked to Lower Risk of Early-Onset Cancer

Early-life sugar restriction during pregnancy and infancy was associated with a 34% lower risk of…

2 days ago

Domain-Specific Physical Activity and Dementia Risk

Higher levels of physical activity were associated with lower risks of all-cause dementia, Alzheimer’s disease,…

5 days ago

BMI and Waist Circumference Jointly Predict Mortality Risk in Older Adults

In US adults aged ≥65 years, overweight and class I–II obesity were associated with lower…

5 days ago

Longitudinal Heart Stress Status Predicts CVD and Mortality in Older Adults

In community-dwelling older adults without prior cardiovascular disease (CVD), new or persistent heart stress (HS)—defined…

6 days ago

The Obesity Paradox in Colorectal Cancer May Reflect Prediagnostic Weight Loss

In the German multicenter study of 5,521 patients with colorectal cancer (CRC), the apparent survival…

1 week ago

Stopping Statins for Primary Prevention After Age 75? Evidence from a Randomized Trial

In adults aged 75 years or older without a history of atherosclerotic cardiovascular disease (ASCVD)…

2 weeks ago

This website uses cookies.